Isogenic mesenchymal stem cells transplantation improves a rat model of chronic aristolochic acid nephropathy via upregulation of hepatic growth factor and downregulation of transforming growth factor β1

Molecular and Cellular Biochemistry

Volumn 368, Issue 1-2, 2012, Pages 137-145

  Li, Wei ^a   Jiang, Hong ^a   Feng, Jiang Min ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Chronic aristolochic acid nephropathy; Hepatic growth factor; Mesenchymal stem cells; Transforming growth factor

Indexed keywords

ARISTOLOCHIC ACID; CREATININE; HEMOGLOBIN; MESSENGER RNA; NITROGEN; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA1; UREA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARISTOLOCHIA; ARISTOLOCHIA MANSHURIENSIS; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ELECTRON MICROSCOPY; FEMALE; HEMOGLOBIN BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; KIDNEY FIBROSIS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; RAT; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE SECTION; UREA NITROGEN BLOOD LEVEL; URINALYSIS; WESTERN BLOTTING;

ANIMALS; ARISTOLOCHIA; ARISTOLOCHIC ACIDS; BONE MARROW CELLS; DOWN-REGULATION; FEMALE; FIBROSIS; HEPATOCYTE GROWTH FACTOR; KIDNEY DISEASES; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; RATS; RATS, WISTAR; TRANSFORMING GROWTH FACTOR BETA1; TRANSPLANTATION, ISOGENEIC; UP-REGULATION;

ANIMALIA; ARISTOLOCHIA MANSHURIENSIS; RATTUS; RATTUS NORVEGICUS;

EID: 84864326956     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-012-1352-5     Document Type: Article

References (23)

1. Vanherweghem JL, Depierreux M, Tielemans C et al (1993) Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet 341:387-391 (Pubitemid 23048140)
2. Nortier JL, Martinez MC, Schmeiser HH, Arlt VM, Bieler CA, Petein M, Depierreux MF, De Pauw L, Abramowicz D, Vere-erstraeten P, Vanherweghem JL (2000) Urothelial carcinoma associated with the use of a Chinese herb (Aristolochiafangchi). N Engl J Med 342:1686-1692 (Pubitemid 30354515)
3. Tanaka A, Nishida R, Maeda K, Sugawara A, Kuwahara T (2000) Chinese herb nephropathy in Japan presents adult-onset Fanconi syndrome: could different components of aristolochic acids cause a different type of Chinese herb nephropathy? Clin Nephrol 53: 301-306 (Pubitemid 30204939)
4. Yang CS, Lin CH, Chang SH, Hsu HC (2000) Rapidly progres-sive fibrosing interstitial nephritis associated with Chinese herbal drugs. Am J Kidney Dis 35:313-318
5. Grollman AP, Jelakovic B (2007) Role ofenvironmental toxins in endemic (Balkan) nephropathy. October 2006, Zagreb, Croatia. J Am Soc Nephrol 18:2817-2823
6. De Jonge H, Vanrenterghem Y (2008) Aristolochic acid: the common culprit of Chinese herbs nephropathy and Balkan endemic nephropathy. Nephrol Dial Transplant 23:39-41 (Pubitemid 351767414)
7. Lai MN, Lai JN, Chen PC, Hsieh SC, Hu FC, Wang JD (2010) Risks of kidney failure associated with consumption of herbal products containing Mu Tong or Fangchi: a population-based case-control study. Am J Kidney Dis 55:507-518
8. Vanherweghem JL, Abramowicz D, Tielemans C, Depierreux M (1996) Effects of steroids on the progression of renal failure in chronic interstitial renal fibrosis: a pilot study in Chinese herbs nephropathy. Am J Kidney Dis 27:209-215 (Pubitemid 26055132)
9. Wang JS, Shum-Tim D, Galipeau J, Chedrawy E, Eliopoulos N, Chiu RC (2000) Marrow stromal cells for cellular cardiomyo-plasty: feasibility and potential clinical advantages. J Thorac Cardiovasc Surg 120:999-1005
10. Tang YL, Tang Y, Zhang YC, Qian K, Shen L, Phillips MI (2005) Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector. J Am Coll Cardiol 46:1339-1350 (Pubitemid 41615559)
11. Reinders ME, Fibbe WE, Rabelink TJ (2010) Multipotent mes-enchymal stromal cell therapy in renal disease and kidney transplantation. Nephrol Dial Transplant 25:17-24
12. Kunter U, Rong S, Djuric Z, Boor P, Muller-Newen G, Yu D, Floege J (2006) Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis. J Am Soc Nephrol 17:2202-2212 (Pubitemid 44141910)
13. Nakagawa T, Lan HY, Glushakova O, Zhu HJ, Kang DH, Schreiner GF, Bottinger EP, Johnson RJ, Sautin YY (2005) Role of ERK1/2 and p38 mitogen-activated protein kinases in the regulation of thrombospondin-1 by TGF-beta1 in rat proximal tubular cells and mouse fibroblasts. J Am Soc Nephrol 16: 899-904 (Pubitemid 41710300)
14. Li Y, Spataro BC, Yang J, Dai C, Liu Y (2005) 1,25-Di-hydroxyvitamin D inhibits renal interstitial myofibroblast acti-vation by inducing hepatocyte growth factor expression. Kidney Int 68:1500-1510 (Pubitemid 43173380)
15. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147 (Pubitemid 29282067)
16. Sun D, Feng J, Sun L, Jin T, Wang Z, Ma J, Wang L (2006) Mechanism of early anemia in rat model of chronic aristolochic acid nephropathy. Chin J Nephrol 22:237-242
17. Singaravelu K, Padanilam BJ (2009) In vitro differentiation of MSC into cells with a renal tubular epithelial-like phenotype. Ren Fail 31:492-502
18. Yang L, Li X, Wang H (2007) Possible mechanisms explaining the tendency towards interstitial fibrosis in aristolochic acid-induced acute tubular necrosis. Nephrol Dial Transplant 22: 445-456 (Pubitemid 46189888)
19. Li JH, Zhu HJ, Huang XR, Lai KN, Johnson RJ, Lan HY (2002) Smad7 inhibits fibrotic effect of TGF-Beta on renal tubular epi-thelial cells by blocking Smad2 activation. J Am Soc Nephrol 13:1464-1472 (Pubitemid 34579235)
20. Zhou L, Fu P, Huang XR, Liu F, Chung AC, Lai KN, Lan HY (2010) Mechanism of chronic aristolochic acid nephropathy: role of Smad3. Am J Physiol Renal Physiol 298:F1006-F1017
21. Vargas GA, Hoeflich A, Jehle PM (2000) Hepatocyte growth factor in renal failure: promise and reality. Kidney Int 57:1426-1436 (Pubitemid 30207902)
22. Yang J, Liu Y (2003) Delayed administration of hepatocyte growth factor reduces renal fibrosis in obstructive nephropathy. Am J Physiol Renal Physiol 284:F349-F357 (Pubitemid 36114697)
23. Mizuno S, Matsumoto K, Kurosawa T, Mizuno-Horikawa Y, Nakamura T (2000) Reciprocal balance of hepatocyte growth factor and transforming growth factor-beta 1 in renal fibrosis in mice. Kidney Int 57:937-948 (Pubitemid 30434784)